GRI Bio, Inc. ( GRI) - Stock Earnings
GRI Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
GRI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.7 million USD | — USD |
| 2026Q1 | -2.0 million USD | — USD |
| 2026Q2 | -1.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GRI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.0 million USD | 21.8 million USD |
| 2024 | -8.2 million USD | 22.5 million USD |
| 2025 | -12.0 million USD | — USD |
| 2026 Est. | — | — |
GRI
Price: $1.38
Earnings Per Share: 39.79 USD
P/E Ratio: 0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2375
Market Capitalization: 4.3 million